Mojisola Adeyeye, the director-general of the National Agency for Food and Drug Control (NAFDAC) has said that Nigeria will continue with hydroxychloroquine trials for the treatment of COVID-19.
The statement by Adeyeye came after the World Health Organisation ordered the trial to be stopped throughout the globe.
However, the NAFDAC boss said that the pill has proven strong enough to cure coronavirus at its emergent stage, according to data released by the agency, TVC reports.
Adeyeye said: “There is data to prove that hydroxychloroquine worked for many COVID-19 patients. Therefore, we would continue our own clinical trials in Nigeria.
“Hydroxychloroquine has been proved to work at a mild stage. So the potency depends on the severity of the disease in the patient’s body.”
